Back
CRISPR Therapeutics AG Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
49
CRSP
CRISPR Therapeutics AG
Last Price:
$54.50
Seasonality Move:
9.38%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRSP is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRISPR Therapeutics AG Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.09 | Buy |
| 20-day SMA: | 55.85 | Buy |
| 50-day SMA: | 58.16 | Sell |
| 200-day SMA: | 51.3 | Buy |
| 8-day EMA: | 56.4 | Buy |
| 20-day EMA: | 56.1 | Buy |
| 50-day EMA: | 56.43 | Buy |
| 200-day EMA: | 38.14 | Buy |
CRISPR Therapeutics AG Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 51.37 | Buy |
| Chaikin Money Flow: | 559526 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (52.25 - 57.53) | Buy |
| Bollinger Bands (100): | (52.44 - 65.38) | Sell |
CRISPR Therapeutics AG Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for CRISPR Therapeutics AG Stock
Is CRISPR Therapeutics AG Stock a Buy?
-
CRISPR Therapeutics AG share price is 56.71 while CRSP 8-day simple moving average is 56.09, which is a Buy signal.
-
The stock price of CRSP is 56.71 while CRISPR Therapeutics AG 20-day SMA is 55.85, which makes it a Buy.
-
CRISPR Therapeutics AG 50-day simple moving average is 58.16 while CRSP share price is 56.71, making it a Sell technically.
-
CRSP stock price is 56.71 and CRISPR Therapeutics AG 200-day simple moving average is 51.30, creating a Buy signal.
CRSP Technical Analysis vs Fundamental Analysis
Sell
49
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy or a Sell?
-
CRISPR Therapeutics AG stock is rated a SellThe current CRISPR Therapeutics AG [CRSP] share price is $56.71. The Score for CRSP is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
CRISPR Therapeutics AG Stock Info
Market Cap:
5.4B
Price in USD:
56.71
Share Volume:
653K
CRISPR Therapeutics AG 52-Week Range
52-Week High:
78.48
52-Week Low:
30.04
Sell
49
CRISPR Therapeutics AG (CRSP)
is a Sell
CRISPR Therapeutics AG Share Price Forecast
-
What is the CRISPR Therapeutics AG stock price today?The CRISPR Therapeutics AG stock price is 56.71 USD today.
-
Will CRSP stock go up or go down?CRISPR Therapeutics AG> share price is forecast to RISE/FALL based on technical indicators
-
Is CRISPR Therapeutics AG overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, CRISPR Therapeutics AG is overvalued.
Is CRISPR Therapeutics AG Stock a Buy?
-
CRISPR Therapeutics AG share price is 56.71 while CRSP 8-day exponential moving average is 56.40, which is a Buy signal.
-
The stock price of CRSP is 56.71 while CRISPR Therapeutics AG 20-day EMA is 56.10, which makes it a Buy.
-
CRISPR Therapeutics AG 50-day exponential moving average is 56.43 while CRSP share price is 56.71, making it a Buy technically.
-
CRSP stock price is 56.71 and CRISPR Therapeutics AG 200-day simple moving average is 38.14, creating a Buy signal.
Fundamental Analysis of CRISPR Therapeutics AG
Is CRISPR Therapeutics AG a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.09 per share, and an increase next year of $1.74 per share.
Technical Analysis of CRISPR Therapeutics AG
Should I short CRISPR Therapeutics AG stock?
-
CRSP Moving Average Covergence Divergence (MACD) indicator is -0.01, suggesting CRISPR Therapeutics AG is a Sell
-
CRISPR Therapeutics AG Relative Strength Index (RSI) is 51.37, which suggest CRISPR Therapeutics AG is overbought
-
The Bollinger Bands (25) for CRISPR Therapeutics AG is (52.25 - 57.53), which suggest CRISPR Therapeutics AG is a Sell
-
The Bollinger Bands (100) for CRISPR Therapeutics AG is (52.44 - 65.38), which suggest CRISPR Therapeutics AG is a Sell
* CRISPR Therapeutics AG stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.